Compounded GLP-1 + B12 Oral Troches | Appetite & Metabolic Weight Support | Superior Health & Wellness
Compounded GLP-1 + B12 Oral Troches | Appetite & Metabolic Weight Support | Superior Health & Wellness
Compounded GLP-1 + B12 Oral Troches | Appetite & Metabolic Weight Support | Superior Health & Wellness
Compounded GLP-1 + B12 Oral Troches | Appetite & Metabolic Weight Support | Superior Health & Wellness

Compounded GLP-1 + B12 Oral Troches | Appetite & Metabolic Weight Support

$0.00

GLP-1 Receptor Support with Vitamin B12 for Appetite and Metabolic Regulation

This compounded oral strip formulation is designed to support appetite regulation, metabolic balance, and blood sugar management in eligible patients. Compounded GLP-1 receptor therapy works by activating natural pathways involved in satiety signaling, digestion, and metabolic regulation. By slowing gastric emptying and enhancing the body’s natural fullness signals, this treatment may help reduce calorie intake and support medically supervised weight management programs.

Vitamin B12 is included in the formulation to support cellular energy metabolism and nervous system function. Some patients may experience improved energy levels or reduced fatigue while receiving treatment. The oral strip dissolves in the mouth and allows medication absorption through oral tissues for convenient administration.

This oral compounded formulation is prescribed for eligible patients under provider supervision. It is not FDA-approved for safety or efficacy and is not equivalent to brand-name GLP-1 medications. Results may vary. Review important medication safety information.

Pricing is provided for reference only. All medications require a valid prescription from a Superior provider and are dispensed directly by our partnering pharmacies — not sold through this website.

Request Information About::

GLP-1 Receptor Support with Vitamin B12 for Appetite and Metabolic Regulation

This compounded oral strip formulation is designed to support appetite regulation, metabolic balance, and blood sugar management in eligible patients. Compounded GLP-1 receptor therapy works by activating natural pathways involved in satiety signaling, digestion, and metabolic regulation. By slowing gastric emptying and enhancing the body’s natural fullness signals, this treatment may help reduce calorie intake and support medically supervised weight management programs.

Vitamin B12 is included in the formulation to support cellular energy metabolism and nervous system function. Some patients may experience improved energy levels or reduced fatigue while receiving treatment. The oral strip dissolves in the mouth and allows medication absorption through oral tissues for convenient administration.

This oral compounded formulation is prescribed for eligible patients under provider supervision. It is not FDA-approved for safety or efficacy and is not equivalent to brand-name GLP-1 medications. Results may vary. Review important medication safety information.

Pricing is provided for reference only. All medications require a valid prescription from a Superior provider and are dispensed directly by our partnering pharmacies — not sold through this website.

The availability of specific medication types may vary and is subject to pharmacy supply.

    1. Oral

    • May support appetite regulation and improved satiety

    • May support healthy metabolic function and blood sugar regulation

    • May assist with medically supervised weight management efforts

    • Vitamin B12 may support cellular energy metabolism and nerve health

  • Common side effects may include:

    • Nausea or upset stomach

    • Vomiting or diarrhea

    • Constipation

    • Decreased appetite

    • Abdominal discomfort

    Serious side effects may include inflammation of the pancreas, gallbladder problems, severe allergic reactions, vision changes, or symptoms of low blood sugar. Seek immediate medical attention if severe symptoms occur.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088.

  • Compounded GLP-1 therapies may increase the risk of serious adverse events including inflammation of the pancreas, gallbladder disease, kidney problems related to dehydration, or possible thyroid tumors observed in animal studies. Do not use this medication if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

    Patients should inform their healthcare provider if they have a history of pancreatitis, gallbladder disease, kidney disease, diabetic eye disease, or mental health concerns before starting therapy. Patients who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using this medication.

Medical Disclaimers: This compounded formulation is intended for patients who meet clinical criteria for weight management support. It has not been reviewed by the FDA for safety or efficacy. It is not a commercial formulation and should not be confused with FDA-approved GLP-1 receptor agonists. This summary does not include all information about the product listed and does not replace medical advice. Always consult your healthcare provider or pharmacist for complete safety information, potential interactions, and individualized recommendations. All prescriptions are based on individual lab results and are provided only at the discretion of a licensed provider. Results may vary. Treatment outcomes depend on individual patient health, labs, and provider recommendations. These statements have not been evaluated by the FDA. Product images are for mock-up and branding purposes only. Actual medications and packaging may vary based on pharmacy fulfillment.